{"id":338079,"date":"2026-10-28T15:56:14","date_gmt":"2026-10-28T14:56:14","guid":{"rendered":"https:\/\/www.echosens.com\/?p=338079"},"modified":"2026-10-28T16:05:07","modified_gmt":"2026-10-28T15:05:07","slug":"masld-mash-infiammazione-epatica-stratificazione-rischio","status":"publish","type":"post","link":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/","title":{"rendered":"Dalla MASLD alla MASH: come identificare l&#8217;infiammazione epatica e stratificare il rischio"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":338111,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_searchwp_excluded":"","footnotes":""},"categories":[49103],"tags":[],"class_list":["post-338079","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-webinar-it","topic-clinical-it"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MASLD e MASH: identificare l&#039;infiammazione epatica<\/title>\n<meta name=\"description\" content=\"Il 25% degli adulti italiani \u00e8 a rischio. Come identificare, stratificare la progressione verso MASH e orientare i pazienti nella pratica clinica.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MASLD e MASH: identificare l&#039;infiammazione epatica\" \/>\n<meta property=\"og:description\" content=\"Il 25% degli adulti italiani \u00e8 a rischio. Come identificare, stratificare la progressione verso MASH e orientare i pazienti nella pratica clinica.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/\" \/>\n<meta property=\"og:site_name\" content=\"Echosens\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fibroscan.echosens\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-28T14:56:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-28T15:05:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.echosens.com\/wp-content\/uploads\/2026\/10\/WEBINAR-ITALY-INFLAMMATION.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Alice Alzon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Echosens\" \/>\n<meta name=\"twitter:site\" content=\"@Echosens\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alice Alzon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/\"},\"author\":{\"name\":\"Alice Alzon\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/#\\\/schema\\\/person\\\/9d222bd7401fa3c0b746bf4e872cb640\"},\"headline\":\"Dalla MASLD alla MASH: come identificare l&#8217;infiammazione epatica e stratificare il rischio\",\"datePublished\":\"2026-10-28T14:56:14+00:00\",\"dateModified\":\"2026-10-28T15:05:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/\"},\"wordCount\":13,\"publisher\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/WEBINAR-ITALY-INFLAMMATION.png\",\"articleSection\":[\"Webinar\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/\",\"url\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/\",\"name\":\"MASLD e MASH: identificare l'infiammazione epatica\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/WEBINAR-ITALY-INFLAMMATION.png\",\"datePublished\":\"2026-10-28T14:56:14+00:00\",\"dateModified\":\"2026-10-28T15:05:07+00:00\",\"description\":\"Il 25% degli adulti italiani \u00e8 a rischio. Come identificare, stratificare la progressione verso MASH e orientare i pazienti nella pratica clinica.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/WEBINAR-ITALY-INFLAMMATION.png\",\"contentUrl\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/WEBINAR-ITALY-INFLAMMATION.png\",\"width\":1920,\"height\":1080,\"caption\":\"webinar | Come inquadrare la malattia epatica in caso di epatosteatosi | 19 novembre 2026\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/masld-mash-infiammazione-epatica-stratificazione-rischio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dalla MASLD alla MASH: come identificare l&#8217;infiammazione epatica e stratificare il rischio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/\",\"name\":\"Echosens\",\"description\":\"Un site utilisant WordPress\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":[\"Organization\",\"MedicalOrganization\"],\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/#organization\",\"name\":\"ECHOSENS\",\"url\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ECHOSENS\"},\"image\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/fibroscan.echosens\",\"https:\\\/\\\/x.com\\\/Echosens\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/echosens\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC1myqoq18t1dKPTz0u1eEgg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/it\\\/#\\\/schema\\\/person\\\/9d222bd7401fa3c0b746bf4e872cb640\",\"name\":\"Alice Alzon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g\",\"caption\":\"Alice Alzon\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MASLD e MASH: identificare l'infiammazione epatica","description":"Il 25% degli adulti italiani \u00e8 a rischio. Come identificare, stratificare la progressione verso MASH e orientare i pazienti nella pratica clinica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/","og_locale":"it_IT","og_type":"article","og_title":"MASLD e MASH: identificare l'infiammazione epatica","og_description":"Il 25% degli adulti italiani \u00e8 a rischio. Come identificare, stratificare la progressione verso MASH e orientare i pazienti nella pratica clinica.","og_url":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/","og_site_name":"Echosens","article_publisher":"https:\/\/www.facebook.com\/fibroscan.echosens","article_published_time":"2026-10-28T14:56:14+00:00","article_modified_time":"2026-10-28T15:05:07+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2026\/10\/WEBINAR-ITALY-INFLAMMATION.png","type":"image\/png"}],"author":"Alice Alzon","twitter_card":"summary_large_image","twitter_creator":"@Echosens","twitter_site":"@Echosens","twitter_misc":{"Written by":"Alice Alzon","Est. reading time":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/#article","isPartOf":{"@id":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/"},"author":{"name":"Alice Alzon","@id":"https:\/\/www.echosens.com\/it\/#\/schema\/person\/9d222bd7401fa3c0b746bf4e872cb640"},"headline":"Dalla MASLD alla MASH: come identificare l&#8217;infiammazione epatica e stratificare il rischio","datePublished":"2026-10-28T14:56:14+00:00","dateModified":"2026-10-28T15:05:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/"},"wordCount":13,"publisher":{"@id":"https:\/\/www.echosens.com\/it\/#organization"},"image":{"@id":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2026\/10\/WEBINAR-ITALY-INFLAMMATION.png","articleSection":["Webinar"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/","url":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/","name":"MASLD e MASH: identificare l'infiammazione epatica","isPartOf":{"@id":"https:\/\/www.echosens.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/#primaryimage"},"image":{"@id":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2026\/10\/WEBINAR-ITALY-INFLAMMATION.png","datePublished":"2026-10-28T14:56:14+00:00","dateModified":"2026-10-28T15:05:07+00:00","description":"Il 25% degli adulti italiani \u00e8 a rischio. Come identificare, stratificare la progressione verso MASH e orientare i pazienti nella pratica clinica.","breadcrumb":{"@id":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/#primaryimage","url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2026\/10\/WEBINAR-ITALY-INFLAMMATION.png","contentUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2026\/10\/WEBINAR-ITALY-INFLAMMATION.png","width":1920,"height":1080,"caption":"webinar | Come inquadrare la malattia epatica in caso di epatosteatosi | 19 novembre 2026"},{"@type":"BreadcrumbList","@id":"https:\/\/www.echosens.com\/it\/masld-mash-infiammazione-epatica-stratificazione-rischio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.echosens.com\/it\/"},{"@type":"ListItem","position":2,"name":"Dalla MASLD alla MASH: come identificare l&#8217;infiammazione epatica e stratificare il rischio"}]},{"@type":"WebSite","@id":"https:\/\/www.echosens.com\/it\/#website","url":"https:\/\/www.echosens.com\/it\/","name":"Echosens","description":"Un site utilisant WordPress","publisher":{"@id":"https:\/\/www.echosens.com\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.echosens.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":["Organization","MedicalOrganization"],"@id":"https:\/\/www.echosens.com\/it\/#organization","name":"ECHOSENS","url":"https:\/\/www.echosens.com\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.echosens.com\/it\/#\/schema\/logo\/image\/","url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg","contentUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg","width":1,"height":1,"caption":"ECHOSENS"},"image":{"@id":"https:\/\/www.echosens.com\/it\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/fibroscan.echosens","https:\/\/x.com\/Echosens","https:\/\/www.linkedin.com\/company\/echosens\/","https:\/\/www.youtube.com\/channel\/UC1myqoq18t1dKPTz0u1eEgg"]},{"@type":"Person","@id":"https:\/\/www.echosens.com\/it\/#\/schema\/person\/9d222bd7401fa3c0b746bf4e872cb640","name":"Alice Alzon","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g","caption":"Alice Alzon"}}]}},"_links":{"self":[{"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/posts\/338079","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/comments?post=338079"}],"version-history":[{"count":10,"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/posts\/338079\/revisions"}],"predecessor-version":[{"id":338115,"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/posts\/338079\/revisions\/338115"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/media\/338111"}],"wp:attachment":[{"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/media?parent=338079"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/categories?post=338079"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.echosens.com\/it\/wp-json\/wp\/v2\/tags?post=338079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}